Introduction
Chronic non-communicable diseases (CNCDs) are the leading cause of death worldwide,
representing approximately 70 % of deaths among individuals aged from 30 to 70 years.
Within the CNCDs setting, cardiovascular diseases (CVDs) are of significant importance,
as they are the leading cause of death and are among the factors that influence disability
and years of life lost, having a significant social and economic impact on the population's
quality of life 1.
For some of these CVDs, the use of oral anticoagulants (OACs) is recommended, as these
medications are widely used in patients with clinical conditions that undesirably
activate blood coagulation, acting both to prevent and treat thromboembolic events,
such as pulmonary and venous thromboembolism, atrial fibrillation, acute myocardial
infarction, and heart valve prostheses, among others 2,3.
Laboratory tests are used to monitor blood coagulation, such as partial thromboplastin
time and prothrombin time, expressed by the international normalized ratio [INR] 4. As the risk of bleeding from excessive doses or thrombus formation at low doses
is high, strict control of INR is required on a monthly, fortnightly, or weekly basis,
through laboratory tests, as well as guidance on the normal range and effective therapeutic
adherence, making oral anticoagulation therapy effective in preventing and treating
thromboembolic events 5,6.
In the case of individuals who are using OACs, therapeutic adherence is an even greater
challenge, as it is for the healthcare professionals who work in this setting, as
it encompasses important aspects such as prescribed medication and adequate control,
as well as changes in dietary habits 7. In the presence of CVDs, a low adherence rate not only increases the mortality and
hospitalization rate but also significantly reduces the effectiveness of treatments
8.
The World Health Organization (WHO) defines adherence to medication therapy as the
extent to which a person's behavior (taking medication, following a diet and/or making
lifestyle changes) corresponds to the recommendations agreed upon with a healthcare
professional 9. Adherence to any proposed treatment includes patient adaptation through active participation
that goes beyond strictly following medication therapy and is associated with lifestyle
changes, education, knowledge about the treatment, and various intervening sociodemographic
and clinical factors 10,11.
In this context, outpatient clinics specializing in OACs aim to provide patients with
follow-up care and guidance on the necessary medication, as well as on the factors
that can interfere with the therapy 12. The systematic review by Salmasi et al. (2020) shows that up to 30 % of patients
with atrial fibrillation are non-adherent, suggesting that there is a significant
therapeutic challenge for this patient population. The work of professional nurses
has been a distinguishing factor in this scenario since educational measures that
improve patients' knowledge, developed by such professionals, can contribute to adherence
to therapy, and specialized services for the follow-up of these patients favor the
development of these measures, which enables a closer relationship between professionals
and patients 13.
In light of the above, the complexity of the management and follow-up of patients
using OACs is remarkable since several factors can influence adherence to therapy,
exposing them to the risk of hemorrhagic or thromboembolic events and associated complications,
increasing the number of hospitalizations, as well as morbidity and mortality.
Considering that sociodemographic and clinical variables can influence therapeutic
adherence, the aim of this study was to identify the factors related to patient treatment
adherence with OACs in outpatient follow-up.
Materials and Methods
Study Type and Setting
This is a descriptive, cross-sectional study, with a quantitative approach. The study
was conducted at the oral anticoagulant outpatient clinic of the Emergency Cardiology
Unit of the Universidade de Pernambuco, which is a reference center for cardiology
in northern and northeastern Brazil, located in the city of Recife, Pernambuco.
The study is part of a larger project entitled "Development and Validation of Technologies
for Telenursing Management in Oral Anticoagulation."
Population and Sample
The population consisted of patients using OACs receiving follow-up at an outpatient
clinic specializing in anticoagulation. The sample was calculated for finite populations,
considering an N of 245 patients, with a confidence interval of 95 %% and a sampling
error of 5 %. The calculated sample consisted of 175 patients. The sample analyzed
consisted of 202 patients.
Inclusion and Exclusion Criteria
Patients aged 18 or over, undergoing OAC treatment, and receiving follow-up at the
outpatient clinic, who had been using OACs for three months, were included in the
study. Patients with cognitive deficits, confirmed by the application of the Mini-Mental
State Examination (MMSE), according to the criteria established by Brucki et al. 14, did not participate in this study, as they rendered the study impossible to understand
as well as to apply the questionnaires. The MMSE sets the following cut-off points:
17 for illiterate individuals; 22 for individuals who have between 1 and 4 years of
education; 24 for those who have between 5 and 8 years of education; and 26 when they
have more than 9 years of education or are over 69 years old. These measurements correspond
to the average cut-off score for each education level found in the study by Brucki
et al 14, minus one standard deviation.
Data Collection
Individuals who were waiting for an appointment at the research location during the
data collection period and those who met the aforementioned inclusion criteria were
invited by the researchers to participate in the study. After the research objectives
were presented and participants consented by signing the informed consent form, the
questionnaires were administered via interview. The data collection period ranged
from July to November 2022, and the instrument duration was approximately 15 minutes.
Two questionnaires were used as data collection instruments:
-
A semi-structured questionnaire prepared by the study's researchers, covering sociodemographic
and clinical variables, such as sex, age, ethnicity, marital status, origin, occupation,
monthly income, level of education, number of people living in the same household,
cost of transportation to the outpatient clinic, cost of medication, prescription
of OACs use, type of OAC, dosage, length of treatment, INR, complications, length
of treatment, personal history, and medications in use;
-
An instrument for measuring treatment adherence, which has been adapted and validated
by Carvalho et al. in 2010 for the § OACs use setting (15, 16), and with its internal
consistency measured by a Cronbach's alpha of 0.6, which found the presence of a maximum
effect in the answers to all the items. The instrument consists of seven items, as
follows: How many times have you forgotten to take the anticoagulant? How many times
have you taken the anticoagulant out of the timetable? How many times have you stopped
taking the anticoagulant because you were feeling better? How many times have you
stopped taking the anticoagulant because you were feeling worse or causing problems?
How many times have you changed the anticoagulant dose because you forgot to take
it the day before? How many times have you stopped taking the anticoagulant due to
a shortage of the medicine? How many times have you stopped taking the anticoagulant
for reasons beyond your control? These items assess the individual's behavior regarding
the daily use of the medication. The answers are collected using a six-point ordinal
scale, ranging from 1 - "always" to 6 - "never". The response values for the seven
items are added together and then divided by the total number of items, resulting
in a score ranging from 1 to 6. Subsequently, values equal to or above 5 are categorized
as adherent on this scale, while the remaining values are classified as 0, which indicates
non-adherence. Thus, the scale is converted into a dichotomous "yes/no" format, that
is, adherent/non-adherent, respectively.
Data Treatment and Analysis
The SPSS version 25.0 (Statistical Package for the Social Sciences) for Windows and
Microsoft Excel 365 software were used to analyze the collected data. All the statistical
tests employed a significance level of 5 %% (p-value ≤ 0.05), with p-values lower
than or equal to 0.05 being considered statistically significant.
The results are presented in tabular format, with the respective absolute and relative
frequencies for the categorical variables, providing a clear view of the data distribution.
For the numerical variables, central tendency measurements (mean, median) and dispersion
measurements (standard deviation and range) were used, providing a detailed description
of the behavior of the quantitative variables.
To verify the existence of associations between the categorical variables, the Chi-squared
test and Fisher's exact test were used, the latter being applied in cases where the
expected frequencies in the contingency table cells were lower than 5. These tests
enabled the evaluation of the relationships between the variables and the identification
of statistically significant associations in the data set analyzed.
Ethical Aspects
The study was conducted in compliance with Resolution 466/2012 of the National Health
Council and approved by the Research Ethics Committee with the Certificate of Ethical
Appraisal No. 59677322.5.0000.5192 and Opinion No. 5.512.060.
Results
A total of 202 patients using OACs and receiving specialized outpatient follow-up
participated in the study. Most of them were female (58.40 %), with a mean age of
61.74 years (± 11.84), of mixed ethnicity (59.40 %), and with a partner (54.50 %).
There was also a prevalence of patients with a low income of up to 1 times the minimum
wage (78.20 %), who were unemployed (83.16 %), and with incomplete primary education
(50.50 %). In addition, 86.10 % of the individuals came from the Metropolitan Region
of Recife and reported that they had to pay for transportation (52.55 %) and medication
(83.2 % [Table 1]).
Table 1
Sociodemographic Characterization of Patients Using OACs (N = 202). Recife, Pernambuco,
2022
|
Sociodemographic variables
|
Mean
|
(± sd)
|
|
Age
|
61.74
|
11.84
|
|
|
N
|
%
|
|
Sex
|
|
|
|
Female
|
118
|
58.40
|
|
Male
|
84
|
41.60
|
|
Ethnicity
|
|
|
|
Mixed
|
120
|
59.40
|
|
White
|
42
|
20.80
|
|
Black
|
34
|
16.80
|
|
Indigenous
|
6
|
3.0
|
|
Marital status
|
|
|
|
With a partner
|
110
|
54.50
|
|
Without a partner
|
92
|
45.50
|
|
Income
|
|
|
|
Up to the minimum wage
|
158
|
78.20
|
|
More than the minimum wage
|
44
|
21.80
|
|
Occupation
|
|
|
|
No employment
|
168
|
83.16
|
|
With employment
|
34
|
16.84
|
|
Education
|
|
|
|
Illiterate
|
6
|
3.0
|
|
Incomplete primary education
|
102
|
50.50
|
|
Complete primary education
|
28
|
13.90
|
|
Incomplete secondary education
|
14
|
6.90
|
|
Complete secondary education
|
52
|
25.70
|
|
Origin
|
|
|
|
Metropolitan Region
|
174
|
86.10
|
|
Countryside
|
28
|
13.90
|
|
Expenses with transportation
|
|
|
|
Yes
|
106
|
52.50
|
|
No
|
96
|
47.50
|
|
Expenses with medication
|
|
|
|
Yes
|
168
|
83.20
|
|
No
|
34
|
16.80
|
Regarding the clinical characterization of individuals based on their OACs therapy,
the main referral was for valve replacement (53.90 %), followed by atrial fibrillation
(40.60 %%), with a treatment time longer than six months (94.04 %), and undergoing
Marevan® therapy (85.10 %). In addition, 52.50 % of patients interviewed had an INR outside
the therapeutic target, requiring adjustments to the medication dosage, 28.70 % stated
that they had already suffered hemorrhagic complications, and 23.80 % had suffered
thromboembolic complications. The most frequent comorbidities and medications with
multiple responses were systemic arterial hypertension (91.10 %), followed by having
a sedentary lifestyle (59.40 %), and dyslipidemia (39.60 %), with the use of the following
medications: antihypertensives (91.10 %), statins (37.60 %), and others (24.50 % [Table 2]).
Table 2
Clinical Characteristics of Patients Using OACs (N = 202). Recife, Pernambuco, 2022
|
Clinical Variables
|
N
|
%
|
|
Referral
|
|
|
|
Valve replacement
|
109
|
53.90
|
|
Atrial fibrillation
|
82
|
40.60
|
|
Chagas disease
|
6
|
3.0
|
|
Others
|
5
|
2.5
|
|
Length of treatment
|
|
|
|
Up to six months
|
12
|
5.96
|
|
Over six months
|
190
|
94.04
|
|
Type of OAC
|
|
|
|
Marevan® |
172
|
85.10
|
|
Warfarin® |
30
|
14.90
|
|
Therapy target
|
|
|
|
Below the recommended target
|
62
|
30.70
|
|
Normal* |
96
|
47.50
|
|
Above the recommended target
|
44
|
21.80
|
|
Complications
|
|
|
|
Hemorrhagic
|
58
|
28.70
|
|
Thromboembolic
|
48
|
23.80
|
|
None
|
96
|
47.50
|
|
Comorbidities** |
|
|
|
Systemic arterial hypertension
|
184
|
91.11
|
|
Dyslipidemia
|
80
|
39.60
|
|
Sedentary lifestyle
|
118
|
58.40
|
|
Stress*** |
56
|
27.70
|
|
Diabetes mellitus
|
30
|
14.90
|
|
Chronic kidney disease
|
6
|
3.0
|
|
Smoking
|
18
|
8.90
|
|
Medications in use** |
|
|
|
Antihypertensive
|
184
|
91.11
|
|
Statin
|
76
|
37.60
|
|
Hypoglycemic
|
28
|
13.90
|
|
Antiarrhythmic
|
52
|
25.70
|
|
Antidepressant
|
8
|
4.0
|
|
Others
|
54
|
26.80
|
In the assessment of adherence to therapy, using the ATMT 15,16, 66.3 %% of patients were classified as adherent and 33.7 %% as non-adherent, as
shown in Table 3.
Table 3
Evaluation of Pharmacological Adherence of Patients Undergoing OACs Treatment (N =
202). Recife, Pernambuco, 2022
|
Pharmacological adherence (ATMT)
|
N
|
%
|
|
Adherent
|
134
|
66.30
|
|
Non-adherent
|
68
|
33.70
|
The analysis in Table 4, which evaluates the relationship between sociodemographic and clinical conditions
with the scores for adherence to OAC therapy in patients, yielded significant results
for some variables. Clinical referral showed a statistically significant association
with adherence (p < 0.001), with patients with a referral for valve replacement showing
greater adherence compared to those with a referral for atrial fibrillation and other
conditions.
The length of treatment was also relevant (p = 0.001), with greater adherence among
those who had been undergoing treatment for more than five years. The therapeutic
target showed a significant association (p < 0.001), with greater adherence among
patients outside the therapeutic target. In addition, comorbidities (such as having
a sedentary lifestyle) and the use of antiarrhythmic medication were also significantly
associated with adherence (p = 0.003 and p < 0.001, respectively).
In turn, variables such as sex, income, occupation, level of education, and the presence
of complications showed no significant association with treatment adherence.
Table 4
Relationship between Sociodemographic and Clinical Conditions and ATMT Scores in Patients
Undergoing OAC Treatment (N = 202). Recife, Pernambuco, 2022
|
Variables
|
Adherence
|
|
|
Yes n (%)
|
No n (%)
|
p-value
|
|
Sex
|
|
|
|
|
Female
|
54 (64.3)
|
30 (35.7)
|
0.603 * |
|
Male
|
80 (67.8)
|
38 (32.2)
|
|
|
Income
|
|
|
|
|
Up to the minimum wage
|
102 (64.6)
|
56 (35.4)
|
0.310 * |
|
More than the minimum wage
|
32 (72.7)
|
12 (27.3)
|
|
|
Occupation
|
|
|
|
|
No employment
|
110 (65.5)
|
58 (34.5)
|
0.565 * |
|
With employment
|
24 (70.6)
|
10 (29.4)
|
|
|
Education
|
|
|
|
|
Illiterate
|
4 (66.7)
|
2 (33.3)
|
1.000 ** |
|
Primary education (complete/incomplete)
|
86 (66.2)
|
44 (33.8)
|
|
|
Secondary education (complete/incomplete)
|
44 (66.7)
|
22 (33.3)
|
|
|
Referral
|
|
|
|
|
Atrial fibrillation
|
40 (51.3)
|
38 (48.7)
|
< 0.001 ** |
|
Valve replacement
|
82 (78.8)
|
22 (21.2)
|
|
|
Chagas disease
|
2 (33.3)
|
4 (66.7)
|
|
|
Others
|
10 (71.4)
|
4 (28.6)
|
|
|
Length of treatment
|
|
|
|
|
Up to five years
|
20 (45.5)
|
24 (54.5)
|
0.001 * |
|
Over five years
|
114 (72.2)
|
44 (27.8)
|
|
|
Therapeutic target
|
|
|
|
|
Outside the therapeutic target
|
84 (79.2)
|
22 (20.8)
|
< 0.001 * |
|
Within the therapeutic target
|
50 (52.1)
|
46 (47.9)
|
|
|
Complications
|
|
|
|
|
Yes (hemorrhagic/thromboembolic)
|
68 (64.2)
|
38 (35.8)
|
0.490 * |
|
No
|
66 (68.7)
|
30 (31.3)
|
|
|
Comorbidities (sedentary lifestyle)
|
|
|
|
|
Yes
|
88 (74.6)
|
30 (25.4)
|
0.003 * |
|
No
|
46 (54.8)
|
38 (45.2)
|
|
|
Medications in use (antiarrhythmics)
|
|
|
|
|
Yes
|
22 (42.3)
|
30 (57.7)
|
< 0.001 * |
|
No
|
112 (74.7)
|
38 (25.3)
|
|
Discussion
Regarding the sociodemographic variables of the patients receiving care at the OAC
outpatient clinic, there was a prevalence of females aged over 60, corroborating the
findings of other studies in which, in the setting of OAC use, the female population
was more prevalent 6,17,18. The increased use of anticoagulants in women may be associated with various factors,
from their use during reproductive age to their increased use of healthcare services
compared to men, as well as their higher susceptibility to cardiovascular diseases
19.
Regarding the questions, most patients had an income of up to the minimum wage and
were unemployed, a result also prevalent in other studies 13,20. This may be due to the prevalence of individuals considered to be retired or pensioners,
either due to unemployment or the physical limitations imposed by the comorbidity,
influencing the lack of job opportunities.
In terms of education, the study participants had a low level of education, with most
of them having incomplete primary education, a result found in other studies conducted
with patients undergoing OAC treatment in the public sector 7,21. Patients with a lower level of education may have limited knowledge about their
medication and its importance, leading to a lack of understanding and motivation to
adhere to the prescribed treatment, challenges in understanding and managing potential
medication interactions, dietary restrictions, and other factors that can affect the
effectiveness of OACs. These limitations can contribute to poor adherence and potentially
compromise the maintenance of INR within the therapeutic range.
Regarding the clinical variables, the main referral for anticoagulant therapy was
valve replacement surgery (mechanical and biological). Furthermore, the length of
treatment with OACs was longer than six months, similar to findings in other studies
13,22. Oral anticoagulation with vitamin K antagonists has been the gold standard for preventing
thromboembolism in replaced heart valves since the 1960s. However, more recent studies
report that newer OACs are contraindicated for patients with mechanical heart valves
due to higher rates of thromboembolism and bleeding events compared to conventional
oral anticoagulation 23.
Regarding the associated comorbidities, hypertension stood out in the clinical profile
of the individuals, which is in line with other studies 21,24. This was followed by dyslipidemia and having a sedentary lifestyle, which are risk
factors for developing other cardio-vascular diseases. Comorbidities have an important
role in favoring the use of OACs. In addition, they are prescribed for heart diseases
with high embolic flow, while antiaggregant treatment may be sufficient for the prevention
of low-risk heart diseases and for the treatment of large and small artery diseases
25.
Regarding treatment adherence, participants were adherent to OAC therapy according
to the ATMT scale, a satisfactory result that is in line with other studies where
individuals were also considered to be adherent to treatment 20,26. Thus reasserting the effectiveness of specialized multi-professional outpatient
care and follow-up for individuals who use OACs, favoring therapeutic adherence, which
contributes to the quality of life and promotion of self-care.
In the evaluation of pharmacological adherence and the relationship between sociodemographic
and clinical conditions and adherence to OACs, patients with a clinical referral for
valve replacement, a length of treatment of more than five years, and an INR value
outside the therapeutic target showed greater adherence to treatment.
It should be noted that adherence was self-reported, which may contain some bias.
It is worth noting that poor adherence can lead to unsatisfactory therapy results
and excessive medical care costs. Adherence is a multidimensional concept influenced
by a range of factors, including the medical doctor-patient relationship, the characteristics
of the disease, and the patient's belief system. It is therefore essential to ensure
a high-quality knowledge base, skills, and motivation at the level of the healthcare
system for assessing and improving adherence 27. Adherence is not just a matter of achieving a specific INR value, but also of shared
decision-making, therapeutic alliance, and the overarching success of the therapy.
Valve replacement is associated with a higher thromboembolic risk, and the use of
OACs is essential to prevent serious complications such as thrombosis and systemic
embolism. Studies show that patients undergoing valve replacement are more aware of
the need for continuous use of anticoagulants since any interruption or lack of treatment
adherence can result in serious health risks 28. This understanding leads to greater adherence to the therapeutic regimen, as the
patient understands the critical importance of anticoagulation for the adequate function
of the valve prosthesis.
In addition, a length of treatment of more than five years is associated with increased
adherence due to several factors, including greater familiarity with the therapeutic
regimen, dosage adjustment, and incorporation of the medication into the daily routine
29. Over time, patients tend to adapt to the regular use of their medication, monitor
their state of health, and realize the long-term benefits of adequate INR management.
This behavior is supported by evidence showing that patients with longer treatment
times develop a more stable routine, reducing the incidence of complications and the
risk of non-adherence 30.
The management of the INR outside the therapeutic target is also a relevant factor
in improving adherence to OAC treatment. When the INR is imbalanced, whether too low
or too high, there is an increased risk of both thrombosis and bleeding, which tends
to cause concern among patients and motivates them to strictly follow the prescribed
treatment to avoid these complications 31. Monitoring it regularly and making the necessary adjustments encourages patients
to remain adherent to the treatment to stabilize the INR within the desired therapeutic
range.
Regarding having a sedentary lifestyle, a study that assessed therapeutic adherence
and the knowledge of anticoagulated patients found that it is possible that patients
do not attribute to physical activity its true value in maintaining adequate INR values,
which minimizes the risk of complications related to the use of anticoagulants 13. Given that a sedentary lifestyle can be considered a risk factor for developing
CVDs, it can be inferred that sedentary patients using OACs are more likely to develop
complications related to treatment and the setting of cardiovascular risk imposed
by the disease that requires therapy, thus interfering with treatment adherence.
Regarding the research finding that antiarrhythmics are facilitators for better adherence,
this has also been noted in other studies 22,31, which may be justified by the medication interaction with OACs since Amiodarone,
the most commonly used antiarrhythmic, reduces hepatic metabolism and prothrombin
time, increasing the effect of Warfarin® in the body, which can interfere with and increase the risk of bleeding, making the
patient more susceptible to being outside the recommended therapeutic target, to complications,
and the need for hospitalization, requiring this patient to adhere to the treatment
more rigorously.
Several studies have researched the relationship between sociodemographic variables-such
as sex, income, occupation, level of education, and the presence of complications-and
adherence to OAC treatment. However, the results show that these variables alone have
no significant association with treatment adherence.
Concerning sex, research indicates that men and women tend to behave similarly in
terms of treatment adherence, especially when they are adequately informed and monitored
32. Continued education regarding anticoagulant therapy seems to neutralize gender-related
differences so that both sexes equally understand the importance of adherence to the
therapeutic regimen.
Income and occupation also showed no significant association with adherence. Although
it is common to assume that patients with a higher income or formal occupations have
increased access to healthcare and therefore have better adherence, the data does
not consistently support this hypothesis. Patients from varying income ranges and
occupations seem to have similar levels of treatment adherence when they receive adequate
support and education about the treatment 21.
In the case of education, although it is expected that patients with a higher level
of education will have easier access to understanding the importance of anticoagulant
therapy, this does not necessarily translate into better adherence. Adherence is more
reliant on factors such as social support, adequate medical follow-up, and the patient's
continued education about the treatment than on their level of education alone 33.
Treatment adherence is a complex behavior that entails multiple factors, including
personal motivation, access to the healthcare system, and continued professional support,
which seem to be | more determinant than the mere presence of complications 34. These findings suggest that although sociodemographic and clinical variables have
traditionally been studied, they are not necessarily reliable predictors of adherence
to treatment with anticoagulants. The key factor for adherence seems to be more closely
related to health education, medical and family support, and continued follow-up for
the patient during treatment.
From this perspective, it is essential to develop educational strategies that encourage
understanding the aspects such as the reason why treatment is prescribed and necessary,
the follow-up of laboratory control, the adequate INR values based on the clinical
condition, the possible complications (risk of bleeding and thromboembolic events),
dietary advice, medication interactions, as well as the necessary lifestyle changes
13.
Nurses, as integral members of the multi-professional team that provides care to patients
using anticoagulants, should work to develop educational measures to improve the orientation
process and understanding of individuals 13. These professionals' efforts should also be aimed at providing comprehensive care,
in which individual needs are assessed and patients are encouraged to expose their
challenges in relation to medication use to allow them to develop ideal coping strategies
35.
Identifying these factors could enable nurses and the multi-professional team who
work with OAC users to learn about patients' sociodemographic and clinical profiles,
as well as the factors that contribute to and hinder adherence to the established
therapy, helping with therapeutic follow-up, decision-making, and the implementation
of educational interventions designed to prevent complications related to OAC use,
reduce hospital admissions, implement measures to strengthen adherence to treatment
and change habits, improving patients' quality of life and the related biopsychosocial
factors.
Finally, it should be noted that patients tend to overestimate their medication adherence,
therefore this study may be limited in quantifying self-reported adherence. In addition,
the study may not consider all the relevant variables that influence adherence, since
it is based on an exploratory study of the local reality, and further studies with
a broader scope are recommended.
Conclusion
The present study identified the factors related to adherence to OAC therapy in outpatient
follow-up, covering the complexity involved in OAC treatment, and enabled the characterization
of the population receiving follow-up at the outpatient clinic specializing in OAC,
as well as identifying that clinical factors such as valve replacement, length of
treatment of more than five years, INR outside the therapeutic target, having a sedentary
lifestyle, and use of anti-arrhythmics are important determinants of improved adherence
to OAC treatment.
These findings highlight the importance of continuous follow-up and health education
in managing anticoagulation in patients who face a higher risk of complications, especially
those who have undergone valve replacement and have a long treatment history.
Furthermore, sociodemographic variables such as sex, income, occupation, level of
education, and the presence of complications were not significantly associated with
treatment adherence. These data suggest that treatment adherence with anticoagulants
is more reliant on clinical factors and health behavior than sociodemographic characteristics,
which highlights the need for individualized support for patients using anticoagulants,
with a focus on awareness and regular clinical follow-up.
These results provide input for clinical practice, showing that follow-up strategies
should prioritize patients with longer treatment times and uncontrolled INR, as well
as improving education and continued support to maintain long-term therapeutic adherence.
